Vericel Corp (VCEL)

• Market cap: $2.05B
• 1 day: -0.79%
• 5 days: -1.36%
• 1 month: 0.96%
• 3 months: -13.26%
• 6 months: 13.77%
• Year to date: 12.27%
• 1 year: 15.42%
• 5 years: -21.52%
• 10 years: 1,545.27%
• Sector: Healthcare
• Industry: Biotechnology

About: Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 398